Gainers

• Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regular session. The market value of their outstanding shares is at $2.2 million.
• Vistagen Therapeutics (NASDAQ:VTGN) shares moved upwards by 48.56% to $0.37. The market value of their outstanding shares is at $11.1 million.
• Bullfrog AI Hldgs (NASDAQ:BFRG) stock rose 36.01% to $0.82. The company's market cap stands at $11.1 million.
• Healthcare Triangle (NASDAQ:HCTI) shares moved upwards by 22.0% to $1.05. The market value of their outstanding shares is at $1.7 million.
• Decoy Therapeutics (NASDAQ:DCOY) shares moved upwards by 20.97% to $3.75. The company's market cap stands at $2.0 million.
• AIxCrypto Hldgs (NASDAQ:AIXC) stock increased by 17.01% to $1.65. The market value of their outstanding shares is at $29.7 million.

Losers

• Jaguar Health (NASDAQ:JAGX) stock fell 74.1% to $8.92 during Wednesday's regular session. The market value of their outstanding shares is at $17.9 million.
• Adagio Medical Holdings (NASDAQ:ADGM) shares decreased by 44.33% to $0.27. The market value of their outstanding shares is at $10.7 million.
• IM Cannabis (NASDAQ:IMCC) stock declined by 35.11% to $2.69. The company's market cap stands at $2.5 million.
• Silexion Therapeutics (NASDAQ:SLXN) shares decreased by 22.32% to $0.3. The market value of their outstanding shares is at $2.1 million.
• NewGenIvf Group (NASDAQ:NIVF) shares declined by 20.53% to $0.65. The company's market cap stands at $1.9 million.
• Biomea Fusion (NASDAQ:BMEA) shares decreased by 19.42% to $1.37. The market value of their outstanding shares is at $123.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.